With or without insurance
Receive GLP-1 medications, including Wegovy® or Zepbound™, at an affordable price with or without insurance.
15 - 20% Average Weight Loss
GLP-1 helps people lose 15%-20% of their body weight on average.
Science-Backed
GLP-1 medications, like Wegovy® & Zepbound™ are FDA-approved for type 2 diabetes and have proven effective for weight loss.
GLP-1 medications have been clinically shown to help people lose an average of 15-20% of their body weight.* A Zealthy provider will review your healthcare assessment & prescribe GLP-1 Medication, if appropriate.
FDA-approved
*This estimate derives from Novo Nordisk's Phase 3 clinical trial results which showed 14.9% average weight loss over 68 weeks among people utilized a maximum tolerated dose of 2.4 mg of semaglutide once-weekly. It also derives from Eli Lilly’s SURMOUNT-4 clinical trial results which showed 20% average weight loss over 36 weeks among people utilized a maximum tolerated dose of 10 mg or 15 mg of tirzepatide once-weekly. TTreatment was given in addition to diet and exercise.
No virtual appointments or in-office visits
Semaglutide, active ingredient in Wegovy®, and tirzepatide, active ingredient in Zepbound™, are available if Wegovy® not covered by insurance
Individual results may vary.
Thousands are losing weight with Zealthy
$39 - 1 month box
One-time payment in full at checkout. Not a subscription.